J.M. Tourani

Proven bioequivalence of blood exposure between vinorelbine 80 mg/m² oral and 30 mg/m² IV doses in cancer patients

Hugues Bourgeois, Jan B. Vermorken, G. Dark et al. · Journal of Clinical Oncology · 2005 · 179 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès et al. · Annals of Oncology · 2013 · 111 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient

Claude Soubrane, J.M. Tourani, J.M. Andrieu et al. · Blood · 1993 · 50 citations

Life Sciences, Clinical Sciences, Immunology +12

Changes of Soluble CD16 Levels in Serum of HIV-Infected Patients: Correlation with Clinical and Biologic Prognostic Factors

D. Khayat, C. Soubrane, J.M. Andrieu et al. · The Journal of Infectious Diseases · 1990 · 47 citations

Life Sciences, Clinical Sciences, Immunology +8

Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient

C. Soubrane, J.M. Tourani, J.M. Andrieu et al. · Blood · 1993 · 42 citations · Full text

Life Sciences, Clinical Sciences, Immunology +12